ISRG Ticker Curator

• Strategic pivot to da Vinci 5 aims to accelerate high-margin recurring revenue from instruments and services—the most critical metric for...

• HB Wealth Management buys 1,499 shares of ISRG
• US Bancorp DE boosts its holdings in ISRG
• Backed by solid metrics: ROE 16.58%, net margin 28.38%,...

Feb 27, 2026 Snapshot for Traders:

• Current: 503.53 -3.35 (-0.66%) at 10:07 ET; Latest 503.44
• Day Range: High 504.95, Low 499.70; Prev Close 506.88
• Pivot: 506.72; R1 512.04, S1 501.56
• Near Resistance: 507.38 (RSI 50%); Support 500.01 (1SD)

Hospitals & specialty clinics led the Asia Pacific surgical robots market in 2024, with the overall market projected to reach USD 4.81 billion by 2031 – a high-growth opportunity for ISRG's international expansion.

2025 Performance Highlights

• 🔥 Procedure Volume: Intuitive Surgical grew 2025 procedures 18% to 3.1 million globally, with international growth...

Key for investors: Intuitive Surgical (ISRG) will report their next quarter earnings on April 28, 2026 – prime time to watch for procedure growth and da Vinci updates.

Deep-pocketed investors signal caution on ISRG with 80% bearish trades amid 10 unusual activities.

• Top trades: Bearish $550 call ($87K), $220 call...

Intuitive Surgical reduced its stock price target from $600 to $570, signaling competitive pressures in the surgical robotics market.

ISRG's standout metrics position it ahead of Abbott:

• Procedures up 18% to 3.1M globally in 2025, driving 21% revenue growth with recurring sales at...

Emerging EU rivalry for ISRG: Kawasaki opens Strasbourg R&D hub next month to accelerate Hinotori certification and challenge da Vinci dominance.

-...

• International edge: 2025 procedures outside US up 23% to >1.1M, beating domestic 15% growth
• Long-term tailwind: Aging population to drive da Vinci procedure demand over next decade
• Dual forces signal accelerating momentum for ISRG investors

Analyst Ratings & Targets

• 🔥 RBC Capital Buy Rating: RBC Capital maintains Buy rating on ISRG with $650 target price; analyst success rate 52.9%...

Bearish signals pile up for ISRG investors:

• Lags Dow sharply: -13.1% past 3 months vs. +5.9%; YTD -12.8% vs. +2.3%; past year -16.4% vs. +13.2%.
  -...

• Dakota Wealth Management slashed its ISRG holdings by 63.9% in Q3, dumping 8,291 shares to leave 4,692 shares worth $2.1M.
• Stands out amid...

• Robotics tailwinds boost ISRG: Global medical robots market to hit $72.54B by 2035 at 16.62% CAGR; ISRG projects 13-15% da Vinci growth amid...

Moderate Buy consensus from 25 analysts (1 Sell, 7 Hold, 15 Buy, 2 Strong Buy).

• Avg 12-month target $615.86, 21.67% upside from $506.17.
• Targets range $440 low to $750 high.
• RBC maintains Buy, $650 target – optimism intact for 2026 potential.